Market Research Logo

Recombinant DNA Technology Market - By Types (Expression System and Cloning Vector), By Product (Medical and Non-Medical), By Application (Diseases, Plants, and Others), and By End User (Research Institutes, Biotechnology Companies, and Pharmaceuticals) -

Recombinant DNA Technology Market - By Types (Expression System and Cloning Vector), By Product (Medical and Non-Medical), By Application (Diseases, Plants, and Others), and By End User (Research Institutes, Biotechnology Companies, and Pharmaceuticals) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Report Description
Recombinant DNA technology has allowed the transfer of desired characteristics which is useful to improve the existing systems by controlling expression of target genes. Recombinant DNA technology allows mass production of therapeutic proteins, which are characterized by high level of consistency and stability. The technology has multidisciplinary applications and potential to deal with important aspects of life, for instance, improving health, and enhancing food resources. The genetically modified plants have augmented resistance to viruses and insect attacks, enhanced product yield, and shown increased adaptability for better survival.
Market Dynamics
Rapid technological advancements in the field of genetic engineering to deliver highly efficient therapeutics for disease management and in the field of agriculture are major driving factors for growth of recombinant DNA technology market. For instance, Bac-to-Bac Baculovirus Expression Systems offers a quick and efficient method to produce recombinant baculovirus and can express the desired genes in insect cells and provide high yields of recombinant protein that speeds up the cloning reaction as compared to the time-consuming restriction enzyme cloning, which takes 2–3 days. Also, in 2016, a BioAg Alliance was formed between Monsanto and Novozymes A/S, to improve crop harvests by using products containing naturally-occurring microbes to boost agricultural productivity and expand its product portfolio. However, the adoption of non-biologic therapeutics and higher complexity of the genetically engineered products such as stability of the cell lines, requirement of skilled professionals, and optimum temperature are the factors hindering the market growth.
Key features of the study:

  • This report provides in-depth analysis of recombinant DNA technology market and provides market size (US$ Billion) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2017 – 2025), considering 2016 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
  • It profiles leading players in the global recombinant DNA technology market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, and strategies, and future plans
  • Key companies covered as a part of this study include Thermo Fisher Scientific, Inc., Biogen, Inc., Sanofi Pasteur, Merck & Co., Inc., Pfizer, Inc., Profacgen, Amgen, Inc., and Monsanto Company
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global recombinant DNA technology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the recombinant DNA technology market
Detailed Segmentation:
  • Global Recombinant DNA Technology Market, By Product Type:
  • Recombinant Protein Drugs
  • Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Blood Factors
  • Colony Stimulating Factors
  • Fusion Proteins
  • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
  • Prokaryotic Cells
  • Mammalian Cells
  • Yeats
  • Insect
  • Others
  • Cell and Gene Therapy
  • Gene Editing
  • Global Recombinant DNA Technology Market, By Application:
  • Therapeutics
  • Agriculture
  • Research
  • Global Recombinant DNA Technology Market, By Geography:
  • North America
  • By Product Type:
  • Recombinant Protein Drugs
  • Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Blood Factors
  • Colony Stimulating Factors
  • Fusion Proteins
  • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
  • Prokaryotic Cells
  • Mammalian Cells
  • Yeats
  • Insect
  • Others
  • Cell and Gene Therapy
  • Gene Editing
  • By Application:
  • Therapeutics
  • Agriculture
  • Research
  • By Country:
  • U.S.
  • Canada
  • Latin America
  • By Product Type:
  • Recombinant Protein Drugs
  • Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Blood Factors
  • Colony Stimulating Factors
  • Fusion Proteins
  • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
  • Prokaryotic Cells
  • Mammalian Cells
  • Yeats
  • Insect
  • Others
  • Cell and Gene Therapy
  • Gene Editing
  • By Application:
  • Therapeutics
  • Agriculture
  • Research
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • By Product Type:
  • Recombinant Protein Drugs
  • Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Blood Factors
  • Colony Stimulating Factors
  • Fusion Proteins
  • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
  • Prokaryotic Cells
  • Mammalian Cells
  • Yeats
  • Insect
  • Others
  • Cell and Gene Therapy
  • Gene Editing
  • By Application:
  • Therapeutics
  • Agriculture
  • Research
  • By Country:
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • By Product Type:
  • Recombinant Protein Drugs
  • Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Blood Factors
  • Colony Stimulating Factors
  • Fusion Proteins
  • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
  • Prokaryotic Cells
  • Mammalian Cells
  • Yeats
  • Insect
  • Others
  • Cell and Gene Therapy
  • Gene Editing
  • By Application:
  • Therapeutics
  • Agriculture
  • Research
  • By Country:
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • By Product Type:
  • Recombinant Protein Drugs
  • Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Blood Factors
  • Colony Stimulating Factors
  • Fusion Proteins
  • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
  • Prokaryotic Cells
  • Mammalian Cells
  • Yeats
  • Insect
  • Others
  • Cell and Gene Therapy
  • Gene Editing
  • By Application:
  • Therapeutics
  • Agriculture
  • Research
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • By Product Type:
  • Recombinant Protein Drugs
  • Insulin
  • Human Growth Hormone
  • Erythropoietin
  • Interferon
  • Blood Factors
  • Colony Stimulating Factors
  • Fusion Proteins
  • Others
  • Vaccines
  • Genetically Modified Crops
  • Expression Systems
  • Prokaryotic Cells
  • Mammalian Cells
  • Yeats
  • Insect
  • Others
  • Cell and Gene Therapy
  • Gene Editing
  • By Application:
  • Therapeutics
  • Agriculture
  • Research
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • Company Profiles
  • Thermo Fisher Scientific, Inc.*
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Overview
  • Market Strategies
  • Biogen, Inc.
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Profacgen
  • Amgen, Inc.
  • Monsanto Company
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Industry Trends
Regulatory Scenario
Key Highlights
PEST Analysis
Epidemiology
Impact Analysis
PORTER’s Analysis
4. Global Recombinant DNA Technology Market, By Product Type, 2015 – 2025, (US$ Billion)
Introduction
Market Share Analysis, 2015 and 2025 (%)
Y-o-Y Growth Analysis, 2016 – 2025
Segment Trends
Recombinant Protein Drugs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
Segment Trends
Insulin
Human Growth Hormone
Erythropoietin
Interferon
Blood Factors
Colony Stimulating Factors
Fusion Proteins
Others
Vaccines
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
Genetically Modified Crops
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
Expression Systems
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
Segment Trends
Prokaryotic Cells
Mammalian Cells
Yeats
Insect
Others
Cell and Gene Therapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
Gene Editing
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
5. Global Recombinant DNA Technology Market, By Application, 2015 – 2025, (US$ Billion)
Introduction
Market Share Analysis, 2015 and 2025 (%)
Y-o-Y Growth Analysis, 2016–2025
Segment Trends
Therapeutics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
Agriculture
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
Research
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2015 – 2025, (US$ Billion)
6. Global Recombinant DNA Technology Market, By Region, 2015 – 2025, (US$ Billion)
Introduction
Market Share Analysis, By Region, 2015 and 2025 (%)
Y-o-Y Growth Analysis, For Regions, 2016–2025
North America
Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
U.S.
Canada
Latin America
Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
China
India
Japan
Australia
South Korea
ASEAN
Rest of APAC
Middle East
Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
Market Size and Forecast, By Product Type, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Application, 2015 – 2025, (US$ Billion)
Market Size and Forecast, By Country, 2015 – 2025, (US$ Billion)
South Africa
Central Africa
North Africa
7. Competitive Landscape
Heat Map Analysis
Company Profiles
Thermo Fisher Scientific, Inc.*
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Biogen, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Sanofi Pasteur
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Merck & Co., Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Pfizer, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Profacgen
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Amgen, Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Monsanto Company
Company Overview
Product Portfolio
Key Highlights
Financial Overviews
Market Strategies
Analyst Views
8. Section
References
Research Methodology
About us and Sales Contact
*Browse 38 market data tables and 26 figures on "Recombinant DNA Technology Market - Global forecast to 2025”.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report